Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial pyruvate carrier (MPC) is a protein complex located in the inner mitochondrial membrane that transports pyruvate, generated from glycolysis in the cytosol, into the mitochondrial matrix. This transport step is essential for linking cytosolic and mitochondrial metabolism, enabling pyruvate to enter pathways such as the tricarboxylic acid (TCA) cycle for energy production and biosynthesis. The functional MPC complex consists of two small homologous membrane proteins: MPC1 and MPC2, which form a heterodimer. MPC regulates whether cells favor oxidative or glycolytic metabolism and plays critical roles across various physiological contexts, including embryonic development, immune cell activation, cancer cell stemness, and dopamine synthesis.
Inhibition of pyruvate transport into mitochondria
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial Pyruvate Carrier (MPC).